治療方案 ​

Lipitor®膽固清®

阿托伐他汀 – 全港最多受訪醫生選用的膽固醇藥1

Lipitor®膽固清®（通用名稱：阿托伐他汀鈣［結晶型］atorvastatin calcium［crystalline form］）是一種能降低膽固醇的他汀類藥物。2,3他汀類藥物被證實與減低心臟病和中風風險有直接關係，在大多數情況下是最有效的降膽固醇藥。4​

為何選擇Lipitor®膽固清®

膽固清®經多過400個臨床研究驗証、8萬多名病人參與研究及超過20年的臨床經驗，至今累積的病人年超過2億5千萬。5

根據一項本地醫生調查，膽固清®同時被選為「最多受訪醫生為自己及家人選用」及「全港最多受訪醫生認為膽固清®對腎臟安全性最佳」。1

國際指南建議

Lipitor®膽固清®（atorvastatin）目前為英國國家健康與照顧卓越研究院NICE（National Institute for Health and Care Excellence）、美國心臟協會AHA（American Heart Association）及歐洲心臟病協會ESC（European Society of Cardiology）多個國際指引的一線藥物。6–8​

  • 參考資料PM-COR-22-112808

    1. Ipsos Healthcare 2020 Lipid Lowering Agent Preference Study Interviewed 200 HCPs (Cardiologists, Endocrinologists, Nephrologists, Neurologists and GP/IM/GOPC) in Hong Kong March – May 2020.
    2. About Atorvastatin. National Health Services. 2022. Available at: https://www.nhs.uk/medicines/atorvastatin/. Accessed on February 14, 2023.
    3. Lipitor® (atorvastatin) Prescribing Information. Viatris Healthcare Hong Kong: Version November 2020.
    4. My cholesterol guide: Take action. Live Healthy! American Heart Association. Available at: https://www.heart.org/-/media/files/health-topics/cholesterol/my-cholesterol-guide-english. Accessed on February 14, 2023.
    5. Lipitor® Core Claims Document (C-LIP-GLB-0387). Data on file.
    6. Cardiovascular disease: risk assessment and reduction, including lipid modification. Clinical guideline [CG181]. National Institute for Health and Care Excellence. 2014. Available at: https://www.nice.org.uk/guidance/cg181. Accessed on February 14, 2023.
    7. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/ NLA/PCNA Guideline on the management of blood cholesterol: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):e285-e350.
    8. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-188.

相關疾病

心血管疾病

了解更多...